News
Arizona is bringing back its iconic 'cactus' logo to the McKale Center floor, and asking fans exactly how to do so. The school produced four images of what the court could look like, all of which ...
A business logo appears on all of the company letterhead, communications, marketing and advertising pieces of a business as a graphic representation or symbol for the company. Essentially ...
Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...
TORONTO — Hudson’s Bay Co. made a whopping, 590-page court filing late Monday that offers insight into how Canada’s oldest company is winding down.
WHILE DRIVING TO THE TERMINAL, THE AIRPORT IS UNVEILING THIS NEW LOGO, WHICH WILL BE SHOWN ON THE NORTH SIDE OF ITS BRAND NEW PARKING GARAGE. THE GARAGE WILL ADD 1100 NEW ON SITE PARKING SPACES.
Sitting all day comes with health risks, such as obesity, high blood pressure and blood sugar, and increased cholesterol levels. It may also be linked to death from heart disease and cancer ...
All Elite Wrestling announced Tuesday that the All Out 2025 pay-per-view will be held at Scotiabank Arena in Toronto on Sept. 20. First established in 2019, All Out has occurred six times with ...
The Lute and Bobbi Olson Court at McKale Center hasn’t featured the historic cactus logo for more than a decade. But the Arizona Wildcats are changing that heading into the 2025-26 school year.
The ad misleadingly features the PDRM logo and names the Commercial Crime Investigation Department (CCID), giving the impression of official endorsement. In a statement released yesterday, Bukit Aman ...
Say hello to your new American Idol. The Season 23 “American Idol” finale kicked off on Sunday, May 18 with the three finalists — John Foster, Jamal Roberts, and Breanna Nix — belting out ...
Matthew Herper covers medical innovation — both its promise and its perils. Regeneron Pharmaceuticals said Monday it had entered into an agreement to buy the consumer genetics firm 23andMe out ...
Final overall survival (OS) results from the MARIPOSA trial (NCT04487080) demonstrated a significant OS benefit for the combination of amivantamab-vmjw (Rybrevant) plus lazertinib (Leclaza) compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results